Evaluation of Satisfaction in Patients Receiving PegIntron Pen [peginterferon alfa-2b]/Rebetol [ribavirin] for Hepatitis C

Trial Profile

Evaluation of Satisfaction in Patients Receiving PegIntron Pen [peginterferon alfa-2b]/Rebetol [ribavirin] for Hepatitis C

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jun 2014

At a glance

  • Drugs Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Acronyms SATISFACTION
  • Sponsors Schering-Plough
  • Most Recent Events

    • 07 Aug 2009 Actual patient number changed from (1960) to (1955) as reported by ClinicalTrials.gov.
    • 20 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top